Camp4 Therapeutics (CAMP) Other Gross PP&E Adjustments (2023 - 2026)
Camp4 Therapeutics recorded quarterly Other Gross PP&E Adjustments of $9.3 million in Q1 2026, up 7.78% quarter-over-quarter from $8.6 million in Q4 2025, and up 96.07% year-over-year from $4.7 million in Q1 2025.
Camp4 Therapeutics' Other Gross PP&E Adjustments history runs 4 years deep, the most recent figure standing at $9.3 million for Q1 2026.
- In Q1 2026, Other Gross PP&E Adjustments rose 96.07% year-over-year to $9.3 million; the TTM figure through Mar 2026 stood at $9.3 million (up 96.07% YoY), while the FY2025 annual figure was $8.6 million, up 111.49% from the prior year.
- Other Gross PP&E Adjustments came in at $9.3 million for Q1 2026 at Camp4 Therapeutics, up from $8.6 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $10.5 million in Q2 2025 to a low of $3.0 million in Q3 2024.
- A 4-year average of $7.4 million and a median of $8.6 million in 2023 frame the typical range for Other Gross PP&E Adjustments.
- Across the five-year window, Other Gross PP&E Adjustments plunged 52.37% in 2024 and soared 246.94% in 2025, its largest moves.
- Camp4 Therapeutics' Other Gross PP&E Adjustments stood at $8.6 million in 2023, then slumped by 52.37% to $4.1 million in 2024, then surged by 111.49% to $8.6 million in 2025, then grew by 7.78% to $9.3 million in 2026.
- According to Business Quant data, Other Gross PP&E Adjustments over the past three periods registered $9.3 million, $8.6 million, and $10.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Camp4 Therapeutics | 245.89 Mn | 245.89 Mn | - | 9.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.29 Mn |
| Mar 31, 2026 | 9.29 Mn |
| Dec 31, 2025 | 8.62 Mn |
| Dec 31, 2025 | 8.62 Mn |
| Sep 30, 2025 | 10.37 Mn |
| Sep 30, 2025 | 10.37 Mn |
| Jun 30, 2025 | 10.55 Mn |
| Jun 30, 2025 | 10.55 Mn |
| Mar 31, 2025 | 4.74 Mn |
| Mar 31, 2025 | 4.74 Mn |
| Dec 31, 2024 | 4.07 Mn |
| Dec 31, 2024 | 4.07 Mn |
| Sep 30, 2024 | 2.99 Mn |
| Sep 30, 2024 | 2.99 Mn |
| Dec 31, 2023 | 8.55 Mn |
| Dec 31, 2023 | 8.55 Mn |